Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.


Por: Gómez I, Gimenez P, Garcia I, Zapater P, Frances R, Gonzalez J, Manichanh C, Ramos J, Bellot P, Guarner F and Such J

Publicada: 1 feb 2018 Ahead of Print: 18 ago 2017
Categoría: Hepatology

Resumen:
Norfloxacin administration is useful in preventing bacterial infections in cirrhosis but associated to the generation of resistant species. Rifaximin is known to reach high concentrations in the intestinal lumen without generating relevant resistance in the intestinal flora. Our aim was to compare the effect of Norfloxacin and Rifaximin on intestinal flora composition, bacterial translocation and survival in cirrhotic rats.
ISSN: 14783223





LIVER INTERNATIONAL
Editorial
WILEY-BLACKWELL, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 38 Número: 2
Páginas: 295-302
WOS Id: 000423532900012
ID de PubMed: 28834270

MÉTRICAS